Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 12:36 PM
Ignite Modification Date:
2025-12-25 @ 12:11 PM
NCT ID:
NCT00977561
Group ID:
EG000
Title:
Figitumumab + Cisplatin or Carboplatin + Etoposide
Description:
Figitumumab 20 mg/kg administered IV over 1 hour on Day 2 of Cycle 1 and on Day 1 of subsequent cycles (up to 17 cycles in the absence of further disease progression or intolerable toxicity). Cisplatin 75 mg/m\^2 IV over 1 hour or carboplatin at a dose to attain the target AUC of 5 mg/mL\*min IV over 15-60 minutes on Day 1 (up to 6 cycles) followed by etoposide 100 mg/m\^2 IV over 1 hour on Days 1, 2 and 3 of each cycle (up to 6 cycles or until progression or intolerable toxicity). Each cycle was 21 days cycle.
Deaths Number Affected:
None
Deaths Number At Risk:
None
Serious Number Affected:
4
Serious Number At Risk:
5
Other Number Affected:
5
Other Number At Risk:
5
Study:
NCT00977561
Results Section:
NCT00977561
Adverse Events Module:
NCT00977561